CAM
TMDX icon

Cresset Asset Management’s Transmedics TMDX Stock Holding History

Cresset Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,648
Closed -$263K – 1840
2026
Q1 		$263K Buy
+2,648
New +$345K ﹤0.01% 1332
2024
Q2 		– Sell
-5,136
Closed -$380K – 2169
2024
Q1 		$380K Buy
+5,136
New +$423K ﹤0.01% 1470

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Cresset Asset Management's TMDX Position: Q2 2026 in Review

Cresset Asset Management sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 2,648 shares — an estimated $263K sold.

Cresset Asset Management first reported a position in TMDX in Q1 2024 and held it in 2 quarters. The position peaked at $380K in Q1 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Cresset Asset Management reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Cresset Asset Management sold 2,648 Transmedics shares in Q2 2026, an estimated $263K.
  • Cresset Asset Management first reported a position in Transmedics in Q1 2024 and held it in 2 quarters.
  • Cresset Asset Management's Transmedics position peaked at $380K in Q1 2024.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.